Loading clinical trials...
Loading clinical trials...
The aim of this study is to investigate the association between increased lifetime physical activity and the development of wild-type transthyretin amyloid cardiomyopathy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical University of Graz
Collaborators
NCT06563895 · Amyloidosis, Amyloid Cardiomyopathy, and more
NCT07207811 · Transthyretin Amyloid Cardiomyopathy (ATTR CM)
NCT07382128 · HCM - Hypertrophic Cardiomyopathy, Anderson Fabry Disease, and more
NCT07196839 · Transthyretin (TTR) Amyloid Cardiomyopathy
NCT06291805 · Transthyretin Amyloidosis, Transthyretin Amyloid Cardiomyopathy, and more
Medical University of Graz
Graz
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions